Skip to content

    EPL Ltd

    EPL
    Capital Goods·8 May 2025
    Management Summary

    EPL Ltd delivered a strong Q4 and full year FY25 performance, driven by robust growth in Beauty & Cosmetics and effective cost management, leading to significant margin expansion and improved profitability. The company reduced its net debt, enhanced ROCE, and proposed a higher dividend, while strategically expanding capacity in high-growth markets like Brazil and Thailand amidst a challenging macro environment.

    Highlights

    5
    • Q4 revenue grew by 7.4%, EBITDA by 17.7%, and PAT by 42.4%, marking the 11th consecutive quarter of EBITDA margin expansion.

    • Full year FY25 saw revenue growth of 7.6%, EBITDA growth of 17.5% with 169 basis points margin expansion, and underlying PAT growth of 44.6%.

    • Beauty & Cosmetics segment witnessed over 20% growth in Q4 and 10.3% for FY25, now contributing 48% of total business.

    • Net debt to EBITDA ratio reduced to 0.54x, and ROCE improved to 18% (335 bps expansion) for FY25.

    • Proposed an increased final dividend of Rs. 2.50 per share, leading to a total FY25 dividend of Rs. 5 per share, up from Rs. 4.35 in FY24.

    Concerns

    3
    • AMESA region (particularly India) saw flat overall growth in Q4, partly due to lower intercompany laminate sales.

    • EAP region experienced a sequential EBIT margin drop in Q4, attributed to the Chinese New Year quarter and high technology tax benefit fluctuations, making it seasonal.

    • Management acknowledged a challenging macro environment and softness in FMCG in India.

    What Changed3

    vs Q1 FY26

    Guidance items2 → 7 (+5)Risks discussed1 → 4 (+3)Q&A highlights4 → 8 (+4)
    Key financials

    Metrics

    6

    Periods

    2

    Q4

    4
    • Revenue Growth
      7.4%
      YoY+7.4%
    • EBITDA Growth
      17.7%
      YoY+17.7%
    • PAT Growth
      42.4%
      YoY+42.4%
    • EBITDA Margin
      20.3%
      QoQ+1.7%

    FY25

    2
    • EPS
      ₹11.38
      YoY+44%
    • ROCE
      18%

    Segment breakdown

    Personal Care & Beyond
    20% Q4 Growth10.3% FY25 Growth48% FY25 Contribution
    Oral Care
    5.6% FY25 Growth
    India (AMESA)
    100 bps Q4 Margin Improvement YoY170 bps Q4 Margin Improvement Sequential
    List

    Capital allocation

    4
    high confidence
    CategoryHeadline
    Capex

    ₹380 crores

    new plan · entirely through organic cash flows after paying for all the CAPEX'S and the dividend

    Debt

    0.5x EBITDA

    Dividend

    ₹2.5/share (final)

    Liquidity

    Liquidity disclosed

    Company is a strong cash generating company, delivering over Rs. 100 crores through organic cash flows in FY25 after all capex and dividends.

    Guidance & targets

    7
    CategoryTargetPriority
    Revenue
    Overall Revenue Growth
    double-digit growth
    High
    Profitability
    EBITDA Growth
    ahead of revenue growth
    High
    Profitability
    EBITDA Margin
    20% plus
    High
    Profitability
    ROCE
    definitely cross 20%
    High
    Category Growth
    Beauty & Cosmetics Growth
    strong double-digit growth
    High
    Capex
    Capex Plan
    Rs. 380-390 crore
    High
    Tax Rate
    Effective Tax Rate
    18%-22%
    High

    Brazil Capacity Expansion Operationalization

    this quarter (Q1 FY26)
    CurrentUnderway
    TargetOperational

    Why it matters

    This expansion is key for Beauty & Cosmetics growth and overall capacity.

    We see promising growth potential in Brazil where capacity expansion is underway and expected to be operational in this quarter itself.

    How to verify

    capital_allocation.capex.purposes

    Risks & concerns

    4
    RiskSeverity

    Challenging macro environment

    The company operated in a challenging macro environment during Q4 FY25.Management acknowledged

    medium

    Softness in FMCG in India and China

    There is some softness in FMCG in India and to an extent in China, which are macro challenges.Management acknowledged

    medium

    US Tariffs

    Management expects minimal impact from US tariffs due to local manufacturing, contractual pass-through of duties, and competitive landed costs.Management downplayed

    low

    Customer pushback on margins

    Analyst questioned if FMCG customers would push back on margin increases, but management did not directly address this in the provided quote.Analyst not addressed

    low

    Q&A highlights

    8

    “in Brazil, we are adding capacity essentially for Beauty & Cosmetics because we have already sold out our existing capacity on Beauty & Cosmetics. So we are adding that. Now, specifically, in terms of volume contribution is going to be about 40 million tubes a year... Thailand, we are making an entry as we have said, and the objective in Thailand actually is to start small but scale up fast.”

    Clarifies specific capacity additions and strategic approach for new market entries.

    asked by Sanjesh Jain

    2 min read6 chapters

    Detailed Narrative

    01

    Q4 and Full Year FY25 Performance Overview

    EPL Ltd reported a strong Q4 FY25, with revenue growing by 7.4%, EBITDA by 17.7%, and PAT by 42.4%. This marks the eleventh consecutive quarter of EBITDA margin expansion, which remained robust at over 20%. For the full year FY25, revenue grew by 7.6%, EBITDA by 17.5% with a 169 basis points margin expansion, and underlying PAT increased by 44.6%. The company's EPS improved significantly to Rs. 11.38 in FY25 from Rs. 7.88 in FY24.

    02

    Strategic Focus on Beauty & Cosmetics and High-Growth Markets

    The Beauty & Cosmetics segment was a key growth driver, witnessing over 20% growth in Q4 and 10.3% for the full year, now contributing 48% of the total business. The company is investing in capability and technology, with a healthy order pipeline and new customer wins. Capacity expansion is underway in Brazil, expected to be operational this quarter, adding 40 million tubes annually for Beauty & Cosmetics. A Greenfield project in Thailand is also progressing, slated to contribute from H2 FY26.

    03

    Geographic Performance and Margin Management

    Revenue growth in Q4 was driven by solid performance in the Americas and EAP regions, while Europe recorded modest growth. In AMESA, particularly India, overall growth was flat due to lower intercompany laminate sales, but underlying tube demand remained positive, and margins showed a clear recovery with 100 bps YoY and 170 bps sequential improvement. The sequential EBIT margin drop in EAP was attributed to seasonal factors like the Chinese New Year and high technology tax benefits.

    04

    Capital Efficiency and Shareholder Returns

    EPL demonstrated strong cash flow generation, which helped reduce the net debt to EBITDA ratio to 0.54x and improved ROCE to 18% for FY25, an expansion of 335 basis points. The company proposed an increased final dividend of Rs. 2.50 per share, bringing the total FY25 dividend to Rs. 5 per share, up from Rs. 4.35 in FY24, reflecting a commitment to returning value to shareholders. The planned CAPEX for FY26 is Rs. 380-390 crore, sufficient for growth and new projects.

    05

    Sustainability and Competitive Positioning

    Sustainability remains a core focus, with the sustainable tube mix rising to 33% from 21% last year, enhancing competitive position with global brands focused on ESG. EPL received an A rating from CDP for climate change and water security. The company believes it has a competitive advantage in the US market despite potential tariffs, due to local manufacturing, contractual pass-through of duties, and cost-optimal delivery.

    06

    Outlook and Growth Drivers

    Management expressed confidence in achieving double-digit revenue growth and EBITDA growth ahead of revenue for FY26, driven by momentum in Beauty & Cosmetics, expansion in high-growth markets, and continued margin improvement initiatives. The steady-state tax rate is expected to be between 18-22%. The company aims to leverage its leadership in laminated tubes and innovation in cost-effective solutions to drive growth.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.